Lim James Y, Kuo Jennifer H
Division of Surgical Oncology, Department of Surgery, Oregon Health and Science University, Portland, OR.
Section of Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.
Tech Vasc Interv Radiol. 2022 Jun;25(2):100824. doi: 10.1016/j.tvir.2022.100824. Epub 2022 Mar 10.
Radiofrequency ablation (RFA) is an increasingly popular non-surgical alternative for the treatment of benign thyroid nodules. Although RFA is less invasive than surgery, it is not without its own risks with major complications occurring at a rate ranging up to 3.8% in large systematic reviews. We review the range of minor and major complications that have been described after thyroid RFA and their potential management. We also review recommended post-ablation follow-up schedules as well as expectations on thyroid nodule volume rate reduction after treatment. Long term follow-up is necessary as there can be regrowth of ablated thyroid nodules due to an undertreated nodule margin. Overall, RFA has been shown to be a consistently safe and effective treatment for thyroid nodules with excellent long-term results.
射频消融（RFA）是治疗良性甲状腺结节越来越常用的非手术替代方法。尽管RFA的侵入性比手术小，但它并非没有自身风险，在大型系统评价中，主要并发症的发生率高达3.8%。我们回顾了甲状腺RFA后已报道的各种轻微和严重并发症及其潜在的处理方法。我们还回顾了推荐的消融后随访计划以及对治疗后甲状腺结节体积缩小率的预期。由于消融的甲状腺结节边缘治疗不充分可能会出现结节再生长，因此需要长期随访。总体而言，RFA已被证明是一种治疗甲状腺结节持续安全有效的方法，长期效果良好。
